Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2025 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Risk Factors for Increased Post-Op Pediatric Readmission

May 17, 2016 By JOURNAL OF NEUROSURGERY PUBLISHING GROUP

Researchers at The University of Alabama at Birmingham have determined specific risk factors associated with hospital readmission following pediatric neurosurgery. Some of these are related to the specific surgical procedure performed (for example, cerebral spinal fluid [CSF] shunt placement or CSF shunt revision), others to postoperative complications (such as surgical site infection), and still others to patient demographics (Native American race). The risk factors that were identified are discussed in the article “Risk factors for unplanned readmission within 30 days after pediatric neurosurgery: a nationwide analysis of 9799 procedures from the American College of Surgeons National Surgical Quality Improvement Program, by Brandon A. Sherrod, BS, James M. Johnston, MD, and Brandon G. Rocque, MD, MS, published today online, ahead of print, in the Journal of Neurosurgery: Pediatrics.

Hospital readmission rates are often used to determine the quality of treatment received by patients. The authors undertook this study to identify baseline readmission rates for a variety of pediatric neurosurgical procedures and to determine what risk factors lead to patient readmission in this population.

As the title suggests, the authors pulled data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) Pediatric database. This database contains prospectively collected patient data from 50 participating hospitals; previous studies of readmission focused on data from single institutions. Eligible for the study were 9,799 neurosurgical procedures performed in patients younger than 18 years old. Of these procedures, 1,098 (11.2 percent) were followed by an unplanned hospital readmission within 30 days.

The authors examined relationships between unplanned readmissions and patient demographics, patient comorbidities, preoperative lab values, types of primary surgery undergone during the hospital stay, postoperative complications, and operation and hospital variables (such as need for transfusion, length of hospital stay, or whether the patient was admitted via the emergency department). Both univariate and multivariate analyses were performed.

The overall hospital readmission rate was 11.2 percent, and the time between the primary surgical procedure and readmission was 14.04 ± 7.74 days (mean ± standard deviation).

The four surgical procedures associated with the highest rates of readmission included the following: CSF shunt revision (17.3 percent), repair of a myelomeningocele larger than 5 cm in diameter (15.4 percent), CSF shunt placement (14.1 percent), and craniectomy to remove an infratentorial tumor (13.9 percent).

The strongest predictor of hospital readmission was postoperative infections, with surgical site infection leading the group.

Other independent risk factors for hospital readmission that were identified include postoperative pneumonia, urinary tract infection, sepsis, Native American race, long-term steroid use, need for oxygen supplementation or nutritional support, seizure disorders, and long operative times.

Some of the risk factors, such as infection, can be modified by health professionals. Others, such as the need for oxygen supplementation or nutritional support, cannot be modified, but their presence can identify patients “who could benefit from discharge planning or direct efforts to facilitate safe hospital discharge without readmission.”

When asked, the corresponding author, Dr. Brandon Rocque said, “The importance of this study is the realization that most of the factors that increase the risk of readmission cannot be controlled by physicians or hospitals. We must be careful using readmission as a way to measure quality of care. Counting a readmission as evidence of lower quality care has the potential to unfairly judge a health system.”

Related Articles Read More >

A photo of J&J MedTech SVP and Global Head of Digital Shan Jegatheeswaran.
Where Johnson & Johnson sees opportunity in surgical intelligence
A close of of Medical 21's Maverics graft.
A surgeon’s prayer helped St. Jude Medical founder Manny Villafaña size his latest device
A photo of Forj Medical's Costa Rica manufacturing facility.
Forj Medical opens Costa Rica manufacturing site
An image of the September 2026 Medical Design & Outsourcing magazine featuring the Medtech Big 100 ranking of the world's largest medical device companies.
September 2026 issue: The MDO Medtech Big 100 breaks $500 billion
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2025 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe